1. P-299Baseline computed-tomography (CT)-evaluated sarcopenia predicts toxicity from first-line chemotherapy in metastatic gastric cancer (mGC) patients. (2nd July 2019) Authors: Catanese, S; Aringhieri, G; Cappelli, C; Vivaldi, C; Vitali, S; Pecora, I; Salani, F; Pasquini, G; Balducci, F; Piercarlo, R; Lencioni, M; Vasile, E; Massa, V; Falcone, A; Caramella, D; Fornaro, L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. RET fusions in a small subset of advanced colorectal cancers at risk of being neglected. (10th March 2018) Authors: Pietrantonio, F; Di Nicolantonio, F; Schrock, A B; Lee, J; Morano, F; Fucà, G; Nikolinakos, P; Drilon, A; Hechtman, J F; Christiansen, J; Gowen, K; Frampton, G M; Gasparini, P; Rossini, D; Gigliotti, C; Kim, S T; Prisciandaro, M; Hodgson, J; Zaniboni, A; Chiu, V K Journal: Annals of oncology Issue: Volume 29:Number 6(2018) Page Start: 1394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-029Regorafenib dose escalations in the prospective, observational CORRELATE study in patients with metastatic colorectal cancer. (2nd July 2019) Authors: Ducreux, M; O'Connor, J; Dochy, E; Fiala-Buskies, S; Cervantes, A; Falcone, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PD-027Efficacy of retreatment with anti-EGFRs in metastatic colorectal cancer is not predictable by clinical factors related to prior lines of therapy: a multi-institutional analysis. (2nd July 2019) Authors: Rossini, D; Pagani, F; Pellino, A; Dell'Aquila, E; Liscia, N; Bensi, M; Germani, M; Masi, G; Moretto, R; Santini, D; Salvatore, L; Scartozzi, M; Lonardi, S; Zucchelli, G; Puglisi, F; Vannini, F; Colombo, C; Falcone, A; Pietrantonio, F; Cremolini, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P-279Characterization of mismatch repair deficiency in biliary tract cancer. (2nd July 2019) Authors: Vivaldi, C; Ugolini, C; Orsi, G; Formica, V; Catanese, S; Andrea, C; Andrikou, K; Doldo, E; Pecora, I; Campani, D; Bonetti, L Reggiani; Pasquini, G; Salani, F; Massa, V; Niccoli, C; Lencioni, M; Vasile, E; Gardini, A Casadei; Fornaro, L; Fontanini, G Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PD-015Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies. (2nd July 2019) Authors: Rossini, D; Sbrana, A; Bergamo, F; Manai, C; Santini, D; Ghidini, M; Antoniotti, C; Moretto, R; Marmorino, F; Urbano, F; Ronzoni, M; Noventa, S; Randon, G; Carlomagno, C; Latiano, T; Cordio, S; Granetto, C; Cremolini, C; Falcone, A; Antonuzzo, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. O-013Impact of age and gender on safety and efficacy of first-line FOLFOXIRI/bevacizumab in mCRC: a pooled analysis of TRIBE and TRIBE2 studies. (2nd July 2019) Authors: Zucchelli, G; Marmorino, F; Rossini, D; Aprile, G; Casagrande, M; Lonardi, S; Murgioni, S; Dell'Aquila, E; Tomasello, G; Moretto, R; Antoniotti, C; Borelli, B; Urbano, F; Ronzoni, M; Zaniboni, A; Manglaviti, S; Buonadonna, A; Ritorto, G; Masi, G; Allegrini, G Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-319Longitudinal evaluation of angiogenesis-related circulating biomarkers during second-line treatment with paclitaxel and ramucirumab in advanced gastroesophageal cancer. (2nd July 2019) Authors: Fornaro, L; Vivaldi, C; Orlandi, P; Musettini, G; Pecora, I; Gentile, D; Catanese, S; Lencioni, M; Salani, F; Pasquini, G; Massa, V; Di Desidero, T; Falcone, A; Vasile, E; Bocci, G Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LBA-007Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable mCRC. (2nd July 2019) Authors: Cremolini, C; Antoniotti, C; Lonardi, S; Rossini, D; Morano, F; Cordio, S; Bergamo, F; Marmorino, F; Maiello, E; Passardi, A; Masi, G; Tamburini, E; Santini, D; Grande, R; Zaniboni, A; Granetto, C; Murgioni, S; Aprile, G; Delliponti, L; Boni, L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. O-026Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC). (2nd July 2019) Authors: Argiles, G; Margalef, N Mulet; Valladares-Ayerbes, M; de Prado, J Vieitez; Grávalos, C; Alfonso, P García; Santos, C; Tobeña, M; Sastre, J; Benavides, M; Cano, T; Loupakis, F; Garrote, M Rodriguez; Rivera, F; Goldberg, R; Falcone, A; Bennouna, J; Ciardiello, F; Tabernero, J; Aranda, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗